Insulin-like growth factor binding protein-related protein 1 mediates VEGF-induced proliferation, migration and tube formation of retinal endothelial cells

Current Eye Research

Volumn 36, Issue 4, 2011, Pages 341-349

  Sun, Tao ^a   Cao, Hui ^a   Xu, Lin ^a   Zhu, Bijun ^a   Gu, Qing ^a   Xu, Xun ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Angiogenesis; B Raf; Insulin like growth factor binding protein related protein 1 (insulin like growth factor binding protein 7); Retina; Vascular endothelial growth factor

Indexed keywords

ANGIOGENESIS INHIBITOR; B RAF KINASE; GLYCOPROTEIN; RECOMBINANT PROTEIN; SOMATOMEDIN BINDING PROTEIN RELATED PROTEIN 1; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANTIANGIOGENIC ACTIVITY; APOPTOSIS; ARTICLE; CELL ASSAY; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; COLORIMETRY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; FLOW CYTOMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA CELL; RHESUS MONKEY;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; COLORIMETRY; ENDOTHELIUM, VASCULAR; FLOW CYTOMETRY; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; MACACA MULATTA; PROTO-ONCOGENE PROTEINS B-RAF; RETINAL NEOVASCULARIZATION; RETINAL VESSELS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79952771586     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2010.545498     Document Type: Article

References (41)

1. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med. 2000;6:389-395. (Pubitemid 30208155)
2. Yancopoulos GD, Davis S, Gale NW, et al. Vascular-specific growth factors and blood vessel formation. Nature. 2000;407:242-248.
3. Engerman RL. Pathogenesis of diabetic retinopathy. Diabetes. 1989;38:1203-1206. (Pubitemid 19247412)
4. Fielder AR, Reynolds JD. Retinopathy of prematurity: Clinical aspects. Semin Neonatol. 2001;6:461-475. (Pubitemid 34670089)
5. Aiello LP. Perspectives on diabetic retinopathy. Am J Ophthalmol. 2003;136:122-135.
6. Dorrell M, Uusitalo-Jarvinen H, Aguilar E, et al. Ocular neovascularization: Basic mechanisms and therapeutic advances. Surv Ophthalmol. 2007;52 suppl 1:S3-S19. (Pubitemid 46107520)
7. Castellon R, Hamdi HK, Sacerio I, et al. Effects of angiogenic growth factor combinations on retinal endothelial cells. Exp Eye Res. 2002;74:523-535. (Pubitemid 34757030)
8. Simó R, Carrasco E, García-Ramírez M, et al. Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy. Curr Diabetes Rev. 2006;2:71-98. (Pubitemid 44082952)
9. Hwa V, Oh Y, Rosenfeld RG. The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr Rev. 1999;20:761-787. (Pubitemid 30648894)
10. Burger AM, Leyland-Jones B, Banerjee K, et al. Essential roles of IGFBP-3 and IGFBP-rP1 in breast cancer. Eur J Cancer. 2005;41:1515-1527. (Pubitemid 40981832)
11. Burger AM, Zhang X, Li H, et al. Down-regulation of T1A12/mac25, a novel insulin-like growth factor binding protein related gene, is associated with disease progression in breast carcinomas. Oncogene. 1998;16:2459-2467. (Pubitemid 28258578)
12. Sprenger CC, Damon SE, Hwa V, et al. Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) is a potential tumor suppressor protein for prostate cancer. Cancer Res. 1999;59:2370-2375. (Pubitemid 29242285)
13. Akaogi K, Okabe Y, Sato J, et al. Specific accumulation of tumor-derived adhesion factor in tumor blood vessels and in capillary tube-like structures of cultured vascular endothelial cells. Proc Natl Acad Sci U S A. 1996;93:8384-8389. (Pubitemid 26269567)
14. Kishibe J, Yamada S, Okada Y, et al. Structural requirements of heparan sulfate for the binding to the tumor-derived adhesion factor/angiomodulin that induces cord-like structures to ECV-304 human carcinoma cells. J Biol Chem. 2000;275:15321-15329. (Pubitemid 30337259)
15. Yamauchi T, Umeda F, Masakado M, et al. Purification and molecular cloning of prostacyclin-stimulating factor from serum-free conditioned medium of human diploid fibroblast cells. Biochem J. 1994;303:591-598. (Pubitemid 24317344)
16. St Croix B, Rago C, Velculescu V, et al. Genes expressed in human tumor endothelium. Science. 2000;289:1197-1202. (Pubitemid 30650733)
17. Degeorges A, Wang F, Frierson Jr HF, et al. Distribution of IGFBP-rP1 in normal human tissues. J Histochem Cytochem. 2000;48:747-754. (Pubitemid 30366609)
18. Ono Y, Hashimoto T, Umeda F, et al. Expression of prostacyclin- stimulating factor, a novel protein, in tissues of Wistar rats and in cultured cells. Biochem Biophys Res Commun. 1994;202:1490-1496. (Pubitemid 24265936)
19. Swisshelm K, Ryan K, Tsuchiya K, et al. Enhanced expression of an insulin growth factor-like binding protein (mac25) in senescent human mammary epithelial cells and induced expression with retinoic acid. Proc Natl Acad Sci U S A. 1995;92:4472-4476.
20. Lou DA, Hu FN. Co-distribution of Von Willebrand factor and fibronectin in cultured rhesus endothelial cells. Histochem J. 1987;19:431-438.
21. Lou DA, Hu FN. Specific antigen and organelle expression of a long-term rhesus endothelial cell line. In Vitro Cell Dev Biol. 1987;23:75-85.
22. Yang H, Chaum E. A reassessment of insulin-like growth factor binding protein gene expression in the human retinal pigment epithelium. J Cell Biochem. 2003;89:933-943. (Pubitemid 36927725)
23. Haugk KL, Wilson HM, Swisshelm K, et al. Insulin-like growth factor (IGF)-binding protein-related protein-1: An autocrine/paracrine factor that inhibits skeletal myoblast differentiation but permits proliferation in response to IGF. Endocrinology. 2000;141: 100-102.
24. Wajapeyee N, Serra RW, Zhu X, et al. Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. Cell. 2008;132:363-374. (Pubitemid 351191995)
25. Skeie JM, Mullins RF. Elastin-mediated choroidal endothelial cell migration: Possible role in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2008;49:5574-5580.
26. You JJ, Yang CH, Chen MS, et al. Cysteine-rich 61, a member of the CCN family, as a factor involved in the pathogenesis of proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci. 2009;50:3447-3455.
27. Gupta K, Kshirsagar S, Li W, et al. VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signaling. Exp Cell Res. 1999;247:495-504. (Pubitemid 29394787)
28. Wilson HM, Birnbaum RS, Poot M, et al. Insulin-like growth factor binding protein-related protein 1 inhibits proliferation of MCF-7 breast cancer cells via a senescence-like mechanism. Cell Growth Difer. 2002;13:205-213. (Pubitemid 34651181)
29. Mutaguchi K, Yasumoto H, Mita K, et al. Restoration of insulin-like growth factor binding protein-related protein 1 has a tumor-suppressive activity through induction of apoptosis in human prostate cancer. Cancer Res. 2003;63:7717-7723. (Pubitemid 37466702)
30. Ruan WJ, Lin J, Xu EP, et al. IGFBP7 plays a potential tumor suppressor role against colorectal carcinogenesis with its expression associated with DNA hypomethylation of exon 1. J Zhejiang Univ Sci B. 2006;7:929-932.
31. Chen Y, Pacyna-Gengelbach M, Ye F, et al. Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) has potential tumour-suppressive activity in human lung cancer. J Pathol. 2007;211:431-438. (Pubitemid 46332554)
32. Mercer KE, Pritchard CA. Raf proteins and cancer: B-Raf is identified as a mutational target. Biochim Biophys Acta. 2003;1653:25-40. (Pubitemid 36627818)
33. Chang F, Steelman LS, Shelton JG, et al. Regulation of cell cycle progression and apoptosis by the Ras/Raf/ MEK/ERK pathway. Int J Oncol. 2003;22:469-480.
34. Hüser M, Luckett J, Chiloeches A, et al. MEK kinase activity is not necessary for Raf-1 function. EMBO J. 2001;20:1940-1951. (Pubitemid 32397396)
35. Garnett MJ, Marais R. Guilty as charged: B-Raf is a human oncogene. Cancer Cell. 2004;6:313-319. (Pubitemid 39361432)
36. Galabova-Kovacs G, Matzen D, Piazzolla D, et al. Essential role of B-Raf in ERK activation during extra-embryonic development. Proc Natl Acad Sci U S A. 2006;103:1325-1330. (Pubitemid 43191164)
37. Baxter RC, Binoux MA, Clemmons DR, et al. Recommendations for nomenclature of the insulin-like growth factor binding protein superfamily. Endocrinology. 1998;139:4036. (Pubitemid 28513685)
38. Yamanaka Y, Wilson EM, Rosenfeld RG, et al. Inhibition of insulin receptor activation by insulin-like growth factor binding proteins. J Biol Chem. 1997;272:30729-30734. (Pubitemid 27527507)
39. Lu M, Amano S, Miyamoto K, et al. Insulin-induced vascular endothelial growth factor expression in retina. Invest Ophthalmol Vis Sci. 1999;40:3281-3286.
40. Poulaki V, Qin W, Joussen AM, et al. Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1α and VEGF. J Clin Invest. 2002;109:805-815. (Pubitemid 34263157)
41. Kondo T, Vicent D, Suzuma K, et al. Knockout of insulin and IGF-1 receptors on vascular endothelial cells protects against retinal neovascularization. J Clin Invest. 2003;111:1835-1842. (Pubitemid 38057728)